Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer 2023-03-14 17:01
Antengene Announces IND Approval for the Phase I CLINCH Trial of ATG-022 (Claudin 18.2 ADC) for the Treatment of Advanced or Metastatic Solid Tumors in China 2023-03-14 12:29
Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy 2023-03-14 07:30
AnnJi Pharmaceutical Announced Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Kennedy's Disease Treatment 2023-03-14 06:00
Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU 2023-03-14 05:11
Everest Medicines Announces Silicon Valley Bank Developments Have Minimal Impact on Company 2023-03-13 07:51
AnnJi Pharmaceutical Announced A Licensing Agreement With Avenue Therapeutics To Develop And Commercialize AJ201, A First-In-Class Clinical Asset For The Treatment Of Kennedy's Disease 2023-03-10 19:00
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing 2023-03-10 09:00
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics 2023-03-09 20:01
GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting 2023-03-09 19:00
NIPPON EXPRESS HOLDINGS Strengthens Pharmaceutical Logistics Quality System Globally 2023-03-09 14:57
Estrella Biopharma Announces FDA Clearance of IND Application for Phase I/II Clinical Trial (Starlight-1) of EB103, a CD19-Targeted ARTEMIS® T Cell Therapy, to Patients with B-Cell Lymphomas 2023-03-09 05:15
Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) 2023-03-09 05:00
Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU 2023-03-09 04:51
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise 2023-03-08 22:00
JW Therapeutics Announces Initiation of Clinical Study of Carteyva® in First-line Treatment in Patients with High-Risk Large B-Cell Lymphoma 2023-03-08 17:30
MSCI ESG Updated I-Mab to "A" Rating 2023-03-07 21:02
Medlab Asia and Asia Health returns to Thailand after securing deals worth US$35m in 2022 2023-03-07 16:49
Ceva Santé Animale calls to speed up development of critical new vaccines at VIV Asia 2023 2023-03-07 12:00
GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS 2023-03-07 10:00
1 82 83 84 85 86 377